Doctor profile · Federal record
Dr. John Croke, MD
Dermatology Physician (CMS: Dermatology) · Boston, MA
- NPI 1013994649
- Accepts Medicare
- MIPS 0.0 / 100 · 2023
- 40 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
725 Albany St, Shapiro 8
Boston, MA 021182526
(617) 638-7420
fax (617) 638-7289 - Mailing address
-
720 Harrison Ave, Dob 503
Boston, MA 021182371
Credentials & registration
- NPI registered
- December 2005 — 21 yrs on file
- Profile last updated
- May 20, 2014
- Year of graduation
- 1986 — 40 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Massachusetts #59427
- Medicaid
- MA #110056889A
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1013994649. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
10,965
Distinct HCPCS
10
Medicare allowed
$586,221
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 5,049 | 522 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,360 | 710 | $92 | |
17000 |
Destruction of precancer skin growth, 1 growth | 1,294 | 619 | $48 | |
11102 |
Biopsy of related skin growth, first growth | 901 | 543 | $87 | |
17110 |
Destruction of skin growth, 1-14 growths | 670 | 398 | $117 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 515 | 233 | $176 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 411 | 320 | $58 | |
11103 |
Biopsy of related skin growth, each additional growth | 347 | 207 | $53 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 137 | 119 | $131 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 104 | 79 | $175 |
In context: peer comparison
Among 69 peers in Boston Dermatology Physician, average services per provider: 115. This provider delivers 95× the peer median.Open Payments
Industry payments received
All-time total
$647
Transactions
23
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Leo Pharma INC. | 6 | $158.21 | |
| Janssen Biotech, INC. | 3 | $144.14 | |
| Ucb, INC. | 2 | $96.61 | |
| Dermavant Sciences, INC. | 4 | $60.64 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $43.54 | |
| Galderma Laboratories, L.P. | 2 | $38.44 | |
| Abbvie INC. | 1 | $34.57 | |
| Regeneron Healthcare Solutions, INC. | 1 | $33.99 | |
| Arcutis Biotherapeutics, INC. | 1 | $22.66 | |
| Sun Pharmaceutical Industries INC. | 1 | $14.68 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
967
Patients
575
Total drug cost
$169,426
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 310 | 176 | $5,881 |
| Metronidazole | Generic | 173 | 101 | $11,464 |
| Triamcinolone Acetonide | Generic | 107 | 79 | $868 |
| Fluocinolone Acetonide | Generic | 74 | 54 | $3,653 |
| Doxycycline Hyclate | Generic | 51 | 32 | $774 |
| Betamethasone Dipropionate | Generic | 42 | 22 | $1,773 |
| Alclometasone Dipropionate | Generic | 41 | 37 | $1,049 |
| Mupirocin | Generic | 34 | 30 | $217 |
| Tretinoin | Generic | 31 | 14 | $1,947 |
| Ammonium Lactate | Generic | 28 | 13 | $434 |
Hospital affiliations
Frequently asked questions
What is Dr. John Croke's medical specialty?
Dr. John Croke practices Dermatology Physician in Boston, MA.
Where does Dr. John Croke practice?
Dr. John Croke practices at 725 Albany St, Boston, MA 021182526. Office phone: 6176387420.
What is Dr. John Croke's NPI?
Dr. John Croke's National Provider Identifier (NPI) is 1013994649, issued by NPPES.
Does Dr. John Croke accept Medicare assignment?
Yes. Dr. John Croke accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. John Croke commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.